go to top
A lab technician puts labels on test tubes during research on COVID-19 at Janssen Pharmaceutical. A lab technician puts labels on test tubes during research on COVID-19 at Janssen Pharmaceutical, a Johnson & Johnson subsidiary, in Beerse, Belgium, June 17, 2020 (AP photo by Virginia Mayo).

A COVID-19 Vaccine Is Still Far Off, but Questions of Fair Distribution Can’t Wait

Wednesday, July 15, 2020

The coronavirus pandemic has inspired a great deal of scientific research into developing a vaccine for COVID-19. The process is moving much faster than normal, with more than 155 vaccine candidates currently being developed, 23 of which are already in human trials. Vaccines can take years or even decades to develop and distribute, but the Trump administration is pushing to have one ready by early next year.

Developing a vaccine is one thing, but making it available to people is another issue altogether—one that involves thorny questions of ethics, intellectual property rights, global trade and recouping research costs. ...

To read more,

enter your email address then choose one of the three options below.

Subscribe to World Politics Review and you'll receive instant access to 10,000+ articles in the World Politics Review Library, along with new comprehensive analysis every weekday . . . written by leading topic experts.